These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28926524)

  • 1. Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma.
    Zhang W; Sun Y; Liu L; Li Z
    Med Sci Monit; 2017 Sep; 23():4506-4512. PubMed ID: 28926524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.
    Wei B; Liang J; Hu J; Mi Y; Ruan J; Zhang J; Wang Z; Hu Q; Jiang H; Ding Q
    Med Sci Monit; 2017 Aug; 23():4192-4204. PubMed ID: 28855498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
    Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
    J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.
    Wang Y; Su Y; Ji Z; Lv Z
    Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
    Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
    Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
    Sun J; Zhao B; Du K; Liu P
    Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
    Liang J; Zhang J; Ruan J; Mi Y; Hu Q; Wang Z; Wei B
    Med Sci Monit; 2017 Nov; 23():5504-5514. PubMed ID: 29151113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
    Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
    J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a panel of genes as a prognostic biomarker for glioblastoma.
    Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E
    EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilysin is overexpressed in glioblastoma and related to clinical outcome of patients.
    Wang X; Zhang K; Chen X; Zhao C; Sun Z
    Med Oncol; 2015 Jan; 32(1):363. PubMed ID: 25429835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
    Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
    Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 receptor D is a favorable biomarker of glioblastoma.
    Liu Y; Xie M; Zhou Y; Che L; Zhang B
    J Neurosurg Sci; 2024 Jun; 68(3):320-326. PubMed ID: 35380198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.